Matisse Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,000
Closed -$270K 141
2017
Q4
$270K Hold
10,000
0.12% 110
2017
Q3
$374K Hold
10,000
0.18% 83
2017
Q2
$250K Buy
+10,000
New +$250K 0.13% 98